Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethanol Gel vs Solution for Congenital Venous Malformations
NCT00462462Phase 2Completed
- Sponsor
- Orphagen Therapeutics
- Start
- May 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of gelified ethanol in congenital venous malformation (CVM) (2 arms), sponsored by Orphagen Therapeutics. Primary endpoint: Maximum Plasma Concentration. Started May 2007; status: completed.
02
Drugs
gelified ethanol
03
Conditions
congenital venous malformation (CVM)
Beyond the preview
Go deeper on NCT00462462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462462.